LiveWorld

Articles by LiveWorld

As LiveWorld marks its 30th anniversary and introduces LiveInsight AI™, Chairman and CEO Peter Friedman discusses why human-led, AI-powered intelligence systems are essential for pharma organizations navigating hallucination risk and regulatory scrutiny. He explains how pairing curated data, tailored AI, and human expertise turns raw information into decision-grade insight. Friedman also outlines what will separate pharma organizations that thrive in this new "intelligence economy" from those that fall behind.

Healthcare discovery has changed. Patients, caregivers, and HCPs are no longer moving through a simple path from Google search to a brand website. They are asking AI assistants, exploring social platforms, reviewing authority sources, participating in communities, and relying on AI-generated answers before they ever click through.